BrainStorm Cell Therapeutics regains compliance with Nasdaq

Under 715827949 percent of Brainstorm Cell's traders are aggressively looking to sell. The analysis of the overall investor sentiment regarding Brainstorm Cell Therapeutics suggests that a large number of traders are panicking. Brainstorm Cell's investing sentiment shows overall attitude of investors towards Brainstorm Cell Therapeutics.
  
BrainStorm Cell Therapeutics regains compliance with Nasdaqs minimum closing bid price rule, according to a recent press release.

Read at seekingalpha.com
seekingalpha News
  

Brainstorm Cell Fundamental Analysis

We analyze Brainstorm Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brainstorm Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brainstorm Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Debt To Equity

Debt To Equity Comparative Analysis

Brainstorm Cell is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

Brainstorm Cell Ther Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Brainstorm Cell stock to make a market-neutral strategy. Peer analysis of Brainstorm Cell could also be used in its relative valuation, which is a method of valuing Brainstorm Cell by comparing valuation metrics with similar companies.

Peers

Brainstorm Cell Related Equities

HCWBHCW Biologics   7.69   
0%
100.0%
CUECue Biopharma   6.62   
0%
86.0%
XFORX4 Pharmaceuticals   6.06   
0%
78.0%
GRIGRI Bio   4.76   
0%
61.0%
ALDXAldeyra   4.25   
0%
55.0%
MREOMereo BioPharma   2.73   
0%
35.0%
BCABBioatla   2.17   
0%
28.0%
PLXProtalix Biotherapeutics   2.10   
0%
27.0%
CELCCelcuity LLC   1.96   
0%
25.0%
CRVSCorvus Pharmaceuticals   1.32   
0%
17.0%
TRVITrevi Therapeutics   1.03   
0%
13.0%
HOWLWerewolf Therapeutics   0.75   
0%
9.0%
EWTXEdgewise Therapeutics   0.07   
0%
1.0%
CNTBConnect Biopharma   1.02   
13.0%
0%
INZYInozyme Pharma   1.37   
17.0%
0%
CKPTCheckpoint Therapeutics   1.73   
22.0%
0%
ANTXAN2 Therapeutics   2.56   
33.0%
0%
GBIOGeneration Bio   3.70   
48.0%
0%
DAWNDay One   3.81   
49.0%
0%
TERNTerns Pharmaceuticals   3.88   
50.0%
0%
PASGPassage Bio   4.92   
63.0%
0%
CCCCC4 Therapeutics   5.71   
74.0%
0%

Complementary Tools for Brainstorm Stock analysis

When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk